The AAP 2026 schedule maintains status for vaccines the CDC moved to shared clinical decision-making, aiming to avoid clinician and parent confusion.
US President's Emergency Plan for AIDS Relief (PEPFAR), the global HIV response has entered a second year of structural ...
A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease ...
In 2017, researchers in New Zealand published the first evidence that a vaccine might be able to prevent gonorrhea, a wily ...
The Forum on Microbial Threats hosts public workshops and supports various other events and publications produced by global ...
The mood surrounding US HIV policy in 2026 is markedly different from the cautious optimism that defined much of the past decade. What had once felt like a steady march toward ending the domestic ...
A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results